Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome

Dipenkumar Modi,Abhinav Deol,Seongho Kim,Lois Ayash,Asif Alavi,Marie Ventimiglia,Divaya Bhutani,Voravit Ratanatharathorn,J. Uberti

Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome

2017

Dipenkumar Modi
Abhinav Deol
Seongho Kim
Lois Ayash
Asif Alavi
Marie Ventimiglia
Divaya Bhutani
Voravit Ratanatharathorn
J. Uberti

Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome

Keywords:

Allogeneic hematopoietic stem cell transplant
Diabetes mellitus
Immunology
Progenitor cell
Stem cell
Medicine
Graft-versus-host disease
Transplantation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations